Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,784 | -12,174 | -5,341 | -19,088 | -13,731 |
| Depreciation Amortization | 1,361 | 884 | 412 | 1,090 | 753 |
| Accounts payable and accrued liabilities | 725 | 706 | 244 | -199 | 170 |
| Other Working Capital | -371 | -1,340 | -1,837 | -1,998 | 318 |
| Other Operating Activity | 2,010 | 643 | 295 | 1,505 | 800 |
| Operating Cash Flow | $-18,059 | $-11,281 | $-6,227 | $-18,690 | $-11,690 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,672 | 1,187 | 203 | 1,905 | -280 |
| PPE Investments | -7,636 | -3,454 | -1,508 | -6,399 | -4,120 |
| Purchase Of Investment | N/A | N/A | N/A | -497 | N/A |
| Investing Cash Flow | $-4,964 | $-2,267 | $-1,305 | $-4,991 | $-4,400 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 117,878 | 117,712 | 243 | 107,525 | 107,226 |
| Financing Cash Flow | $117,878 | $117,712 | $243 | $107,525 | $107,226 |
| Beginning Cash Position | 187,514 | 187,514 | 187,514 | 103,670 | 103,670 |
| End Cash Position | 282,369 | 291,678 | 180,225 | 187,514 | 194,806 |
| Net Cash Flow | $94,855 | $104,164 | $-7,289 | $83,844 | $91,136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,059 | -11,281 | -6,227 | -18,690 | -11,690 |
| Capital Expenditure | -7,636 | -3,454 | -1,508 | -6,399 | -4,120 |
| Free Cash Flow | -25,695 | -14,735 | -7,735 | -25,089 | -15,810 |